Zhigang Sun

1.3k total citations
49 papers, 842 citations indexed

About

Zhigang Sun is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zhigang Sun has authored 49 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 17 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Zhigang Sun's work include MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (8 papers) and RNA modifications and cancer (6 papers). Zhigang Sun is often cited by papers focused on MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (8 papers) and RNA modifications and cancer (6 papers). Zhigang Sun collaborates with scholars based in China, United States and Mongolia. Zhigang Sun's co-authors include Nan Zhang, Yong-An Yang, Hai‐Liang Zhu, Tingting Zhao, Na Lü, Kang Hu, Tiantian Wang, Xingsong Tian, Jun Zhang and Shujun Fan and has published in prestigious journals such as PLoS ONE, Experimental Cell Research and Frontiers in Oncology.

In The Last Decade

Zhigang Sun

48 papers receiving 836 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhigang Sun China 18 556 323 122 98 94 49 842
Guoli Wei China 13 406 0.7× 266 0.8× 155 1.3× 71 0.7× 64 0.7× 46 717
Hongyan Jin China 20 879 1.6× 557 1.7× 219 1.8× 65 0.7× 111 1.2× 32 1.3k
Xiaoming Huang China 14 329 0.6× 166 0.5× 119 1.0× 48 0.5× 107 1.1× 54 616
Qiao‐Li Lv China 21 767 1.4× 552 1.7× 124 1.0× 49 0.5× 93 1.0× 64 1.1k
Jingwei Zhang China 16 745 1.3× 561 1.7× 95 0.8× 64 0.7× 55 0.6× 42 956
Sreedevi Avasarala United States 14 632 1.1× 185 0.6× 176 1.4× 29 0.3× 78 0.8× 19 967
Gülçin Tezcan Türkiye 17 519 0.9× 322 1.0× 125 1.0× 31 0.3× 98 1.0× 64 828
Yi Xiao China 19 668 1.2× 344 1.1× 316 2.6× 58 0.6× 79 0.8× 71 1.1k

Countries citing papers authored by Zhigang Sun

Since Specialization
Citations

This map shows the geographic impact of Zhigang Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhigang Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhigang Sun more than expected).

Fields of papers citing papers by Zhigang Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhigang Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhigang Sun. The network helps show where Zhigang Sun may publish in the future.

Co-authorship network of co-authors of Zhigang Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Zhigang Sun. A scholar is included among the top collaborators of Zhigang Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhigang Sun. Zhigang Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Guoxiang, et al.. (2025). Correlation of Peripheral Blood CD4/CD8 Ratio with Efficacy and Prognosis in Patients with Non-Small Cell Lung Cancer Receiving PD-1/PD-L1 Inhibitors. Journal of College of Physicians And Surgeons Pakistan. 35(6). 800–802.
2.
Ma, Chao, et al.. (2024). ZNF217: An Oncogenic Transcription Factor and Potential Therapeutic Target for Multiple Human Cancers. Cancer Management and Research. Volume 16. 49–62. 3 indexed citations
3.
Ma, Chao, et al.. (2022). The molecular mechanism of METTL3 promoting the malignant progression of lung cancer. Cancer Cell International. 22(1). 133–133. 28 indexed citations
4.
5.
Xu, Peng, Kang Hu, Ping Zhang, Zhigang Sun, & Nan Zhang. (2022). Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis. Cancer Cell International. 22(1). 13–13. 25 indexed citations
6.
Ma, Chao, et al.. (2021). Roles of N6‐Methyladenosine Demethylase FTO in Malignant Tumors Progression. OncoTargets and Therapy. Volume 14. 4837–4846. 23 indexed citations
7.
Chen, Runze, Fei Yang, Min Zhang, Zhigang Sun, & Nan Zhang. (2021). Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances. Frontiers in Oncology. 11. 671548–671548. 18 indexed citations
8.
Yin, Qing, et al.. (2021). Clinical and prognostic features of MMP-2 and VEGF in AEG patients. Open Medicine. 16(1). 786–794. 2 indexed citations
9.
Chen, Lin, Zhigang Sun, Hao Xu, et al.. (2021). Emerging roles of circular RNAs in thyroid cancer. Experimental Cell Research. 404(2). 112626–112626. 3 indexed citations
10.
Sun, Zhigang, et al.. (2020). Development and Challenges of the Discovery of HER2 Inhibitors. Mini-Reviews in Medicinal Chemistry. 20(20). 2123–2134. 2 indexed citations
11.
Zhang, Zhen, Luoyan Zhang, Zhigang Sun, et al.. (2020). Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer. Cancer Chemotherapy and Pharmacology. 86(6). 761–772. 55 indexed citations
12.
Guo, Ying, Zhigang Sun, Chi Zhang, et al.. (2019). Correlation between long non-coding RNAs (lncRNAs) H19 expression and trastuzumab resistance in breast cancer. Journal of Cancer Research and Therapeutics. 15(4). 933–933. 26 indexed citations
13.
Tong, Mengying, Wenjing Qi, Shi Chang, et al.. (2019). 5‑Hydroxymethylcytosine as a potential epigenetic biomarker in papillary thyroid carcinoma. Oncology Letters. 18(3). 2304–2309. 17 indexed citations
14.
Sun, Zhigang, et al.. (2018). BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway. Experimental Cell Research. 371(1). 214–221. 11 indexed citations
15.
Sun, Zhigang, Yong-An Yang, Zhigang Zhang, & Hai‐Liang Zhu. (2018). Optimization techniques for novel c-Met kinase inhibitors. Expert Opinion on Drug Discovery. 14(1). 59–69. 20 indexed citations
16.
He, Wei, et al.. (2017). Methylene Tetrahydrofolate Reductase (MTHFR) rs868014 Polymorphism Regulated by miR-1203 Associates with Risk and Short Term Outcome of Ischemic Stroke. Cellular Physiology and Biochemistry. 41(2). 701–710. 19 indexed citations
17.
Sun, Zhigang, et al.. (2017). Co-existence of mucin-producing urothelial-type adenocarcinoma of the prostate and inverted papilloma of the bladder. Współczesna Onkologia. 2(2). 184–187. 3 indexed citations
18.
Sun, Zhigang, Wei Wei, Huawei Liu, et al.. (2017). Acute Response of Neurons: An Early Event of Neuronal Cell Death After Facial Nerve Injury. World Neurosurgery. 109. e252–e257. 7 indexed citations
19.
Hu, Guozhang, Bo Wei, Lina Wang, et al.. (2015). Analysis of gene expression profiles associated with glioma progression. Molecular Medicine Reports. 12(2). 1884–1890. 17 indexed citations
20.
Zhang, Changfu, Kai Chen, Zhe Chen, et al.. (2014). The Clinical Significance of DC-SIGN and DC-SIGNR, which Are Novel Markers Expressed in Human Colon Cancer. PLoS ONE. 9(12). e114748–e114748. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guoli Wei Breakdown of academic impact, for papers by Hongyan Jin Breakdown of academic impact, for papers by Xiaoming Huang Breakdown of academic impact, for papers by Qiao‐Li Lv Breakdown of academic impact, for papers by Jingwei Zhang Breakdown of academic impact, for papers by Sreedevi Avasarala Breakdown of academic impact, for papers by Gülçin Tezcan Breakdown of academic impact, for papers by Yi Xiao
Rankless by CCL
2026